Ponstan
Ponstan
- In our pharmacy you can buy ponstan (mefenamic acid) without a prescription; availability varies by country and in many places it remains prescription-only, though some pharmacies and online suppliers sell it OTC or without a receipt.
- Ponstan is used for acute mild-to-moderate pain and primary dysmenorrhea; it is a non-steroidal anti-inflammatory drug (a fenamate) that reduces pain and inflammation by inhibiting prostaglandin synthesis via reversible cyclooxygenase (COX) inhibition.
- Usual adult dose: 500 mg initially, then 250 mg every 6 hours as needed (do not exceed recommended duration—typically up to 1 week for acute pain and 2–3 days for dysmenorrhea); not recommended for children under 14 years and use caution in the elderly.
- Oral administration: capsules or tablets (commonly 250 mg; some markets have 500 mg) and oral suspension formulations for children in certain regions.
- Onset of effect is usually within about 30–60 minutes after oral dosing.
- Duration of analgesic action is approximately 6 hours (hence dosing every 6 hours as needed); overall short courses are recommended.
- Avoid or limit alcohol while taking ponstan, as alcohol increases the risk of gastrointestinal irritation, bleeding and may worsen drowsiness.
- The most common side effect is stomach pain/dyspepsia (also nausea, vomiting, headache, dizziness and skin rash are commonly reported).
- Would you like to try ponstan without a prescription?
Basic Ponstan Information
- INN (International Nonproprietary Name): Mefenamic acid
- Brand Names Available In Canada (English): not specified
- ATC Code: M01AG01
- Forms & Dosages: Capsules 250 mg; Tablets 250 mg and 500 mg; Oral suspension 50 mg/5 ml and 100 mg/5 ml (Asia)
- Manufacturers In Canada (English): not specified
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions; some OTC availability in select Asian markets depending on formulation and country regulations
Instructions & Quick Warnings For Canadian Patients
Ponstan is the common name patients use for mefenamic acid, which is the International Nonproprietary Name listed on product labels.
Treat mefenamic acid as a prescription NSAID and check for a valid Drug Identification Number (DIN) on any product in Canada before use.
Use should be short-term only: up to one week for acute pain and 2–3 days per period for dysmenorrhea, following standard dosing regimens.
Do not use mefenamic acid if there is a known allergy to NSAIDs or salicylates, active peptic ulcer, severe hepatic or renal impairment, or for peri-operative CABG pain.
Avoid combining mefenamic acid with anticoagulants or antiplatelet drugs without medical advice due to increased bleeding risk.
When travelling from rural to urban areas, carry a copy of prescriptions and a current medication list so pharmacists can confirm the DIN and formulation.
Expect bilingual labelling on Canadian products and check provincial plans such as the Ontario Drug Benefit, BC PharmaCare, or RAMQ for coverage details.
Note that the Ponstel brand has been discontinued in some U.S. markets, but generics and international brands remain available.
Always consult a pharmacist at Shoppers Drug Mart, Rexall, London Drugs or your local community pharmacy to verify the DIN and provincial coverage options.
Everyday Use & Best Practices
Morning Vs Evening Dosing In Canadian Routines
Start the initial dose when pain begins, for example take the first 500 mg in the morning if cramps or pain start on waking.
The typical adult dosing is an initial 500 mg followed by 250 mg every six hours as needed, with the usual short-term limit of one week for acute pain.
For primary dysmenorrhea begin at the onset of menses using the same 500 mg then 250 mg q6h regimen for 2–3 days each period.
If drowsiness or dizziness occurs, avoid taking the last dose within two hours of bedtime to reduce night-time impairment.
For shift workers or people with variable schedules set phone reminders every six hours rather than tying doses to clock times.
Taking With Or Without Meals (Canadian Diet Context)
Taking mefenamic acid with a light meal or snack helps reduce the chance of stomach upset.
If you work in remote or northern areas where access to food is limited, carry a small snack to pair with doses.
- Quick Tip: Pair doses with a piece of toast, yogurt, or a granola bar when possible.
- Quick Tip: Avoid taking doses on an empty stomach if you have a history of dyspepsia.
- Quick Tip: If nausea occurs, stop the medication and speak with your pharmacist or prescriber.
| Meal | Sample Pairing |
|---|---|
| Breakfast | Toast and yogurt |
| Lunch | Sandwich or soup with crackers |
| Snack | Granola bar or small piece of fruit |
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Do not use mefenamic acid with a known allergy to mefenamic acid, NSAIDs, or salicylates.
Patients with asthma or urticaria that is triggered by NSAIDs should not take mefenamic acid.
Active peptic ulcer disease, gastrointestinal bleeding, severe renal impairment, severe hepatic impairment, or peri-operative CABG pain are absolute contraindications.
Elderly patients and those with cardiovascular disease need extra caution because of higher gastrointestinal and cardiovascular risk.
Always confirm whether the product being dispensed has a Health Canada-issued DIN and ask the pharmacist for safety notices relevant to the product.
Activities To Limit (Driving, Workplace Safety)
Mefenamic acid may cause dizziness, drowsiness, or visual disturbances in some people.
Avoid driving or operating heavy machinery until you know how mefenamic acid affects you.
- Do Not Do: Drive or operate heavy equipment after taking a dose if you feel dizzy or drowsy.
- Do Not Do: Combine mefenamic acid with alcohol if you must perform safety-sensitive tasks.
Workers in safety-sensitive roles such as commercial drivers, heavy equipment operators, pilots, and those in occupational health programs should document NSAID use and confirm fitness for duty with occupational health.
Dosage & Adjustments
General Regimen (DIN References)
The standard adult regimen is a 500 mg initial dose followed by 250 mg every six hours as needed, with a usual maximum short-term duration of one week for acute pain.
For primary dysmenorrhea start at the onset of menses with 500 mg then 250 mg q6h for 2–3 days per period.
In Canada, prescription products should display a DIN; record the DIN for insurance claims and to verify the exact formulation dispensed.
Capsules of 250 mg are common, and tablet forms of 250 mg and 500 mg appear in different markets.
Pediatric oral suspensions (50 mg/5 ml or 100 mg/5 ml) exist in some markets, but children under 14 years are generally not recommended in several jurisdictions.
Special Cases (Elderly, Comorbidities)
Elderly patients should use the lowest effective dose for the shortest possible time because of increased GI and cardiovascular risks.
Severe renal impairment is a contraindication; mild-to-moderate renal impairment requires dose reduction and monitoring of renal function.
Severe hepatic impairment is also a contraindication; liver function tests should be monitored in patients with hepatic disease.
If a patient is on anticoagulants or antiplatelet agents, consult prescriber or pharmacist to consider alternatives or monitoring.
| Population | Adjustment / Advice |
|---|---|
| Elderly | Use lowest effective dose; monitor for GI/CV signs |
| Severe Renal Impairment | Contraindicated |
| Mild–Moderate Renal Impairment | Use caution; consider lower dose and monitor creatinine |
| Severe Hepatic Impairment | Contraindicated |
- Pharmacist Checklist: Verify DIN, review recent renal/hepatic labs, check concurrent anticoagulants or multiple NSAIDs.
User Testimonials
Positive Reports From Canadian Patients
Many Canadians post that mefenamic acid, often sold as Ponstan or as generic mefenamic acid, provides rapid relief for menstrual cramps.
Common praise notes relief within about an hour and fewer tablets are needed due to the initial 500 mg loading dose.
Patients appreciated when pharmacy staff explained the DIN, formulation, and whether provincial coverage applied.
Common Challenges In Forums (Reddit Canada, Health Boards)
Negative reports often mention stomach upset, dizziness, or difficulty getting a specific brand such as Ponstel when it is discontinued in some regions.
Confusion regularly appears around prescription-only status and coverage under plans like ODB or PharmaCare.
Advice for people posting experiences: include the dose you took, timing, any side effects, and the pharmacy source to help others interpret the report.
- Checklist For Posting: Dose, Timing, Side Effects, Outcome, Pharmacy Source
Buying Guide
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
In Canada mefenamic acid is usually obtained by prescription from community pharmacies, including chains such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs.
Ask your pharmacist to confirm the DIN and whether the product is a brand or generic mefenamic acid.
Rural clinics and smaller pharmacies may need to order stock, so call ahead if you rely on a specific formulation or brand.
Pharmacists can advise on provincial prior authorization or formulary alternatives when public plans have restrictions.
Price Comparison (In-Store Vs Online, Cross-Border Notes)
Price varies between in-store retail and licensed Canadian online pharmacies; always check for a valid DIN on any online offer.
Avoid international imports without a DIN as these may not meet Canadian regulatory standards.
Ponstel capsules have been discontinued in some markets, while generics such as Meftal or Ponstan are more common internationally.
| Source | Typical Notes |
|---|---|
| In-Store Canadian Pharmacy | DIN-verified; pharmacist counsel; possible provincial coverage |
| Licensed Canadian Online Pharmacy | Comparable prices; discreet shipping; check DIN and pharmacist contact |
| Cross-Border / International Supplier | Generics available; avoid imports without DIN; regulatory differences apply |
- What To Check: DIN, prescription requirement, expiry date, and pharmacy licence.
In our online pharmacy, ponstan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
What’s Inside & How It Works
Ingredients Overview
The active ingredient is mefenamic acid, a fenamate-class NSAID listed under ATC code M01AG01.
Common dosage forms are 250 mg capsules and 250 mg or 500 mg tablets; paediatric suspensions are available in some Asian markets.
Excipients vary by manufacturer, so ask a pharmacist for the full ingredient list if you have allergies or religious dietary requirements.
Canadian products should show a DIN and bilingual labelling on the package.
Mechanism Basics
Mefenamic acid inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis and thereby decreasing pain and uterine cramping.
This COX inhibition is why mefenamic acid works well for prostaglandin-mediated dysmenorrhea but also why it carries typical NSAID risks such as gastrointestinal bleeding and renal effects.
| Active Ingredient | Mechanism | Common Effects / Risks |
|---|---|---|
| Mefenamic Acid | COX-1 / COX-2 Inhibition → ↓ Prostaglandins | Analgesia, reduced uterine cramping; risk of GI bleed, renal impact, increased BP |
Main Indications
Approved Uses In Canada
Mefenamic acid is used for acute mild-to-moderate pain and primary dysmenorrhea in markets where it is authorised.
The typical dosing for these indications is an initial 500 mg followed by 250 mg every six hours as needed, with dysmenorrhea treatment usually limited to 2–3 days per period.
Confirm Health Canada-authorized products and DIN status at the dispensing pharmacy because many mefenamic acid products are prescription-only.
Off-Label Uses By Canadian Physicians
Physicians may sometimes prescribe mefenamic acid off-label for short-term dental pain, musculoskeletal sprains, or postoperative pain where appropriate alternatives are unsuitable.
Off-label prescribing should consider comorbidities, drug interactions, and provincial formularies, with documented informed consent as necessary.
- Approved Indications: Acute pain, Primary dysmenorrhea
- Common Off-Label Uses: Short-term dental pain, Musculoskeletal sprains, Postoperative pain (selected cases)
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
Alcohol increases the risk of gastrointestinal bleeding when combined with mefenamic acid and should be minimised during treatment.
Caffeine has no direct harmful interaction but may add to nervousness or insomnia; adjust intake based on personal tolerance when taking mefenamic acid.
Do not combine mefenamic acid with other OTC NSAIDs such as ibuprofen or naproxen to avoid additive gastrointestinal and renal toxicity.
Drug Conflicts (Health Canada Database)
Key interactions include anticoagulants and antiplatelet agents (e.g., warfarin, DOACs) which increase bleeding risk when used with mefenamic acid.
SSRIs can further increase the risk of gastrointestinal bleeding when combined with NSAIDs.
ACE inhibitors, ARBs, and diuretics may have reduced antihypertensive effect and increased risk of renal impairment when taken with NSAIDs.
| Drug | Risk | What To Do |
|---|---|---|
| Warfarin / DOACs | Increased bleeding risk | Consult prescriber; consider monitoring or alternative analgesic |
| SSRIs | Higher GI bleeding risk | Discuss with pharmacist; watch for GI symptoms |
| ACE Inhibitors / ARBs / Diuretics | Possible reduced antihypertensive effect; renal risk | Check creatinine and BP; monitor renal function |
- Questions To Ask Your Pharmacist: Does this product have a DIN? Are there interactions with my current medications? Do I need monitoring or lab tests?
Latest Evidence & Insights
Clinical data support mefenamic acid as effective for primary dysmenorrhea and for some short-term acute pain conditions versus placebo and comparable to other NSAIDs.
Efficacy often follows a single 500 mg loading dose with relief noted within about an hour and continuation with 250 mg every six hours as needed.
Safety data reflect class-wide NSAID risks such as gastrointestinal bleeding and cardiovascular concerns, especially with longer-term use or in high-risk patients.
Pediatric safety is limited and many jurisdictions do not recommend use in children under 14 years.
| Study / Agency | Population | Outcome | Safety Notes |
|---|---|---|---|
| Short-Term Trials (Various) | Adults with dysmenorrhea | Effective vs placebo; rapid symptom relief | GI upset and NSAID-class risks observed |
| Regulatory Notes | International markets | Brand discontinuations (Ponstel); generics remain | Check local DIN and approvals |
Gaps In Evidence: Long-term safety data for chronic use are limited, so use the lowest effective dose for the shortest time and closely monitor elderly and co-morbid patients.
Alternative Choices
When mefenamic acid is unsuitable, several alternatives are commonly used for similar indications.
- Ibuprofen — pros: widely available OTC and familiar dosing; cons: similar GI and cardiovascular risks as other NSAIDs.
- Naproxen — pros: longer duration between doses; cons: may have comparable or greater GI/CV risks for long-term use.
- Diclofenac / Ketoprofen — pros: effective for inflammatory pain; cons: prescription or restricted OTC forms and variable coverage.
- Paracetamol (Acetaminophen) — pros: fewer GI/CV risks and often preferred in pregnancy with guidance; cons: less effective for prostaglandin-mediated menstrual cramps.
| Drug | Dose Frequency | Availability | Typical Cost |
|---|---|---|---|
| Ibuprofen | Every 4–6 hours | OTC | Low to medium |
| Naproxen | Every 8–12 hours | OTC or Rx (formulation dependent) | Medium |
| Paracetamol | Every 4–6 hours | OTC | Low |
Consider provincial drug plan coverage such as ODB, PharmaCare, or RAMQ and discuss patient-specific factors such as pregnancy, breastfeeding, and cardiovascular history with your pharmacist.
Regulation Snapshot
In Canada any marketed mefenamic acid product should carry a DIN and conform to Health Canada labelling requirements, including bilingual labels.
Mefenamic acid is typically prescription-only in most jurisdictions, so verify the product’s Rx status with your pharmacist before purchase.
Provincial formularies vary on NSAID reimbursement and prior authorization can be required for chronic uses.
- Steps To Confirm Legitimacy: Check the DIN, confirm bilingual labelling, and verify the pharmacy licence or contact your pharmacist.
- Ordering Note: National chains can stock or order mefenamic acid; rural pharmacies may use regional wholesalers for supply.
- Find product → Verify DIN → Confirm coverage with pharmacist
FAQ
| Question | Answer / Action |
|---|---|
| Can I take mefenamic acid with my blood pressure medicine? | Not without checking; NSAIDs can blunt ACE inhibitor/ARB effects and worsen kidney function; have your pharmacist or doctor review current meds and recent labs. |
| Is mefenamic acid safe in pregnancy or breastfeeding? | Generally avoided, especially late pregnancy; breastfeeding guidance varies so consult an obstetrician or pharmacist for individual advice. |
| What if I miss a dose or take too much? | Missed dose: take when remembered unless the next dose is near; do not double. Overdose: seek emergency care for symptoms such as vomiting, drowsiness, renal issues, or convulsions. |
| Can teens use it for cramps? | Adolescents 14 years and older may follow adult dosing; children under 14 are often not recommended—follow prescriber guidance. |
- When To Call A Healthcare Provider: Severe abdominal pain, signs of GI bleeding (black stools), fainting, severe rash, difficulty breathing, or reduced urine output.
Guidelines For Proper Use
Canadian Pharmacist And Provincial Health Authority Recommendations
Before starting mefenamic acid review medical history, current medications including OTCs and supplements, allergies, pregnancy status, and renal/hepatic function.
Pharmacists should confirm the DIN, counsel on short-term use, and advise on provincial coverage such as ODB, BC PharmaCare, or RAMQ.
Use the lowest effective dose for the shortest duration; if pain persists beyond one week for acute pain or beyond 2–3 days per menses for dysmenorrhea consult the prescriber.
Storage, Disposal, Missed Dose & Overdose
Store at 20–25°C, protect from moisture and heat, and keep in the original container away from children.
Dispose of unused or expired medication through pharmacy take-back programs rather than household garbage.
Missed dose: take as soon as remembered unless the next dose is near; do not double the dose.
Overdose: seek immediate medical attention; symptoms can include nausea, vomiting, drowsiness, renal failure, or convulsions.
- Before Taking: Have a current med list, recent renal/hepatic labs if applicable, and confirm allergies.
- While Taking: Watch for GI pain, black stools, dizziness, or swelling and avoid alcohol and other NSAIDs.
- If Problems: Stop medication and contact your pharmacist or go to emergency care for severe reactions.
Contact your provincial health line or local pharmacy for specific support and advice about coverage and urgent questions.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| Windsor | Ontario | 5-9 days |
| London | Ontario | 5-9 days |